EMPAGLOXIT contains Empagliflozin, a SGLT2 inhibitor that have been approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. SGLT2 inhibitors are also known to help improve outcomes in people with heart disease, kidney disease, and heart failure. For this reason, these medications are often used in people with type 2 diabetes who also have heart or kidney problems.
DAPAGLOXIT contains Dapagliflozin, a SGLT2 inhibitor that have been approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. SGLT2 inhibitors are also known to help improve outcomes in people with heart disease, kidney disease, and heart failure. For this reason, these medication is often used in people with type 2 diabetes who also have heart or kidney problems.
ARKAPRES is Clonidine Hydrochloride Tablets available in two strengths of 100 mcg & 150 mcg. Clonidine hydrochloride is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration. Clonidine stimulates alpha-adrenoreceptors in the brain stem. This action results in reduced sympathetic outflow from the central nervous system and in decreases in peripheral resistance, renal vascular resistance, heart rate, and blood pressure.
BENISTO contains Benidipine, also known as Benidipinum or benidipine hydrochloride, is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension). Benidipine not only has an inhibitory effect on muscular (L type) Ca+2 channel, but also have an inhibitory effect on N and T type Ca+2 channels.
LIPIPRES contains Atorvastatin which is a member of the drug class known as statins. It is used for lowering cholesterol. Atorvastatin is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-determining enzyme in cholesterol biosynthesis via the mevalonate pathway. It is the most trusted for the Prevention of Cardiovascular Disease & Hyperlipidemia.